On August 29, 2025, the International Cooperation Department of the China Securities Regulatory Commission issued a filing notice regarding Beijing Tong Ren Tang Medical and Healthcare Investment Co., Ltd.'s overseas issuance and listing, as well as the "full circulation" of unlisted domestic shares (Document No. Guohe Han [2025] 1471).
According to the filing notice, Beijing Tong Ren Tang Medical and Healthcare plans to issue no more than 1.3693 billion overseas-listed ordinary shares for listing on the Hong Kong Stock Exchange, while 10 shareholders intend to convert a total of 1.104 billion unlisted domestic shares into overseas-listed shares.
Beijing Tong Ren Tang Medical and Healthcare submitted prospectuses to the Hong Kong Stock Exchange three times on June 28, 2024, December 31, 2024, and June 30, 2025, with China International Capital Corporation serving as the sole sponsor.
Established in 2015, Beijing Tong Ren Tang Medical and Healthcare operates as a leading Traditional Chinese Medicine (TCM) medical group, primarily leveraging specialized departments and combining TCM pharmaceutical and non-pharmaceutical treatments to provide optimal solutions for clients. As of June 24, 2025, the company has established a tiered medical service network comprising 12 self-owned offline medical institutions and one internet hospital, along with 10 managed offline medical institutions. According to a Frost & Sullivan report, based on total outpatient visits and inpatient admissions in 2024, Beijing Tong Ren Tang Medical and Healthcare is the largest TCM hospital group among China's non-public TCM medical service providers, holding a 1.7% market share.
Prospectus link: https://www1.hkexnews.hk/app/sehk/2025/107518/documents/sehk25063003612_c.pdf
Comments